Diagnosis, Prognosis, and Mechanisms in Panvascular Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-12-01

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to establish a standardized cohort for panvascular diseases, encompassing biological materials such as DNA samples, along with extensive patient medical records and follow-up information. The design of this database will enable it to serve as a comprehensive resource for future medical research.

Upon data collection, researchers will conduct various statistical analyses to enhance our understanding of the factors and mechanisms contributing to various panvascular diseases, including coronary heart disease, myocardial infarction, stroke, and peripheral vascular disease. These statistical analyses will also aid in identifying more effective treatment strategies for these conditions.

By amassing a large volume of data from a significant number of patients with panvascular diseases, researchers will be able to perform highly precise analyses of the factors influencing the onset, progression, and treatment of these diseases. The results of these precise analyses can then be utilized to optimize clinical practices for the prevention and treatment of panvascular diseases.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prospective Cohort Study of Panvascular Disease

NCT06295861

ASCVD

ACTIVE_NOT_RECRUITING

Metabolomics Characterization of Biomarkers of ASCVD and Prediction Model

NCT05148182

Atherosclerosis Prediction Model

UNKNOWN

Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics

NCT06001073

Coronary Artery Disease Arrhythmias, Cardiac Heart Valve Diseases +9 more

RECRUITING

Risk Factors of Individuals With Coronary Artery Disease

NCT00260104

Coronary Artery Disease

UNKNOWN

Multi-omics Merge for Ensemble Subtyping for Atherosclerotic Cardiovascular Disease

NCT06471803

Atherosclerotic Cardiovascular Diseases

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Panvascular diseases are a group of complex disorders affecting the entire vascular system, with their development influenced by multiple risk factors, including genetic susceptibility, metabolic abnormalities (such as hypertension, hyperlipidemia, and diabetes), inflammatory responses, oxidative stress, and unhealthy lifestyle habits (such as smoking and physical inactivity). In-depth research into the mechanisms of these factors can help uncover the core drivers of the disease, providing a theoretical foundation for early prevention and intervention. Additionally, elucidating specific molecular pathways (such as inflammatory signaling, lipid metabolism, and endothelial dysfunction-related pathways) and molecular regulatory mechanisms (such as non-coding RNAs and epigenetic modifications) can offer new targets for precise diagnosis and treatment. By integrating multi-omics data and high-throughput technologies, the molecular networks of panvascular diseases can be systematically clarified, advancing the development of personalized medicine. This will significantly improve patient outcomes, reduce disease burden, and hold substantial scientific value and clinical application prospects.

This study aims to establish a standardized cohort for panvascular diseases, encompassing various biological materials such as DNA samples, as well as comprehensive patient medical records and long-term follow-up information. The database will systematically collect multidimensional data, including patient questionnaire data (e.g., lifestyle, family history, dietary habits), imaging examination results (e.g., ultrasound, CT, MRI), DNA and other biochemical indicators extracted from blood samples, as well as non-invasive physiological parameters such as blood pressure and heart rate, and examinations related to arterial health assessment (e.g., pulse wave velocity, ankle-brachial index). By integrating these multi-source data, researchers will be able to conduct in-depth analyses of the genetic, metabolic, and clinical characteristics of panvascular diseases, identify disease-related biomarkers and predictive factors, and thereby provide a valuable resource for investigating the mechanisms of panvascular diseases.

Based on this database, researchers can systematically explore the risk factors of panvascular diseases and their dynamic evolution patterns, uncovering the key driving mechanisms behind disease development. Furthermore, through high-throughput sequencing, multi-omics analysis, and machine learning technologies, researchers can identify potential molecular targets and therapeutic strategies, advancing the field of precision medicine. These research outcomes will not only contribute to the development of novel diagnostic methods and personalized treatment plans but also provide a scientific basis for the early prevention and intervention of panvascular diseases, ultimately improving patient prognosis and reducing disease burden. The establishment of this resource platform will provide critical support for research and clinical practice in panvascular diseases, holding profound scientific significance and practical value.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Panvascular Diseases Cardiovascular Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male or female aged 18 to 80 years old;
2. Diagnosed or suspected panvascular disease, defined as the presence of atherosclerotic lesions in at least two or more vascular regions, such as intracranial arteries, carotid arteries, coronary arteries, aorta, and peripheral arteries;
3. Voluntary participation in this study and provision of signed informed consent.

Exclusion Criteria

1. Severe hemodynamic instability;
2. Severe cardiac dysfunction (EF \< 30%);
3. Severe arrhythmias;
4. Severe valvular heart disease;
5. Cardiomyopathy caused by non-coronary artery diseases;
6. Non-atherosclerotic coronary artery disease (e.g., coronary artery dissection, embolism, etc.);
7. Severe non-cardiovascular diseases;
8. Women who are pregnant or breastfeeding;
9. Individuals who refuse to provide signed informed consent.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes